CVS Health Ventures
Description
CVS Health Ventures, launched in 2021 with an initial commitment of $100 million, serves as the dedicated corporate venture capital arm of CVS Health. Its primary objective is to strategically invest in and partner with high-potential, early-stage companies that are developing innovative solutions across the healthcare spectrum. The fund aims to identify and support ventures that align with CVS Health's overarching mission to make healthcare more accessible, affordable, and simpler for consumers, leveraging its extensive national footprint and diverse service offerings.
The fund's investment strategy is focused on key areas critical to the future of healthcare, including digital health, care delivery transformation, health technology, and consumer-centric health solutions. CVS Health Ventures actively seeks startups that can enhance its existing capabilities, leverage its vast network of retail pharmacies, Aetna health plan members, and MinuteClinic locations, and contribute to the evolution of integrated healthcare services. Beyond providing capital, the fund offers portfolio companies strategic guidance, operational support, and potential integration opportunities within the expansive CVS Health ecosystem, creating a powerful value proposition for its partners.
Typically, CVS Health Ventures provides initial investments ranging from $5 million to $20 million, primarily targeting Seed to Series B funding rounds. This investment range enables them to support companies through critical growth phases, helping them scale their technologies and services to achieve broader market impact. Through these strategic investments, CVS Health Ventures is committed to fostering innovation that addresses pressing healthcare challenges, from improving patient engagement and chronic disease management to streamlining care coordination and enhancing overall health outcomes, ultimately aiming to reshape the future of healthcare delivery.
Investor Profile
CVS Health Ventures has backed more than 26 startups, with 7 new investments in the last 12 months alone. The firm has led 7 rounds, about 27% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series D rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Medical, Artificial Intelligence (AI).
- Led 2 rounds in the past year.
- Typical check size: $5M – $20M.
Stage Focus
- Series C (31%)
- Series A (27%)
- Series D (15%)
- Series Unknown (12%)
- Series B (8%)
- Series E (4%)
- Pre Seed (4%)
Country Focus
- United States (92%)
- Israel (4%)
Industry Focus
- Health Care
- Medical
- Artificial Intelligence (Ai)
- Machine Learning
- Hospital
- Mental Health
- Personal Health
- Wellness
- Mobile
- Electronic Health Record (Ehr)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
